Approval · Notice of Compliance 5413 · 2004
FACTIVE: Notice of Compliance 5413
Issued September 21, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5413
- Date
- September 21, 2004
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FACTIVE | 02248968 | Cancelled Post Market |
Medicinal ingredients
- GEMIFLOXACIN MESYLATE 320 MG per TAB